Russia approved WTO protocol for the compulsory licensing of pharmaceuticals

drug manufacturing

At a meeting held on April 27, 2017, the Government of the Russian Federation approved the draft federal law “On the Adoption of Protocol Amending the Agreement on Trade-Related Aspects of the Intellectual Property Rights” and decided to submit it to the State Duma in accordance with the established procedure.

The Protocol suggests amending the Agreement with the provisions that define an expanded application of a mechanism allowing World Trade Organization (WTO) members to issue compulsory licenses for manufacturing generic pharmaceuticals for export and to use, where necessary, the exemption to prevent their actions from being challenged by other WTO members. The adoption of the Protocol by Russia will in particular allow Russian manufacturers to produce generic pharmaceuticals by using a foreign patent of original medicinal product in order to help other countries.

The draft law was reviewed and approved on April 24, 2017 at a meeting of the Legislative Drafting Commission of the Russian Government.